Jin-hai Tang

Dr. Jin-hai Tang


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 April 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
WCWei-Xian Chen
Wei-Xian Chen
XLXue-Min Liu
Xue-Min Liu
MLMeng-Meng Lv
Meng-Meng Lv
LCLin Chen
Lin Chen
JZJian-Hua Zhao
Jian-Hua Zhao
JTJin-hai Tang
Jin-hai Tang
Adriamycin and docetaxel are two agents commonly used in treatment of breast cancer, but their efficacy is often limited by the emergence of chemoresistance. Recent studies indicate that exosomes act as vehicles for exchange of genetic cargo between heterogeneous populations of tumor cells, engendering a transmitted drug resistance for cancer development and progression. However, the specific contribution of breast cancer-derived exosomes is poorly understood. Here we reinforced other's report that human breast cancer cell line MCF-7/S could acquire increased survival potential from its resistant variants MCF-7/Adr and MCF-7/Doc. Additionally, exosomes of the latter, A/exo and D/exo, significantly modulated the cell cycle distribution and drug-induced apoptosis with respect to S/exo. Exosomes pre-treated with RNase were unable to regulate cell cycle and apoptosis resistance, suggesting an RNA-dependent manner. Microarray and polymerase chain reaction for the miRNA expression profiles of A/exo, D/exo, and S/exo demonstrated that they loaded selective miRNA patterns. Following A/exo and D/exo transfer to recipient MCF-7/S, the same miRNAs were significantly increased in acquired cells. Target gene prediction and pathway analysis showed the involvement of miR-100, miR-222, and miR-30a in pathways implicated in cancer pathogenesis, membrane vesiculation and therapy failure. Furthermore, D/exo co-culture assays and miRNA mimics transfection experiments indicated that miR-222-rich D/exo could alter target gene expression in MCF-7/S. Our results suggest that drug-resistant breast cancer cells may spread resistance capacity to sensitive ones by releasing exosomes and that such effects could be partly attributed to the intercellular transfer of specific miRNAs.

27 June 2014 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
WCWei-Xian Chen
Wei-Xian Chen
YCYan-Qin Cai
Yan-Qin Cai
MLMeng-Meng Lv
Meng-Meng Lv
LCLin Chen
Lin Chen
SZShanliang Zhong
Shanliang Zhong
JTJin-hai Tang
Jin-hai Tang

27 March 2013 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
WCWei-Xian Chen
Wei-Xian Chen
QHQing Hu
Qing Hu
MQMan-Tang Qiu
Man-Tang Qiu
SZShanliang Zhong
Shanliang Zhong
JXJin-Jin Xu
Jin-Jin Xu
JZJianhua Zhao
Jianhua Zhao

10 November 2015 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
LMLing Mao
Ling Mao
JLJian Li
Jian Li
WCWei-Xian Chen
Wei-Xian Chen
YCYan-Qin Cai
Yan-Qin Cai
DYDan-Dan Yu
Dan-Dan Yu
JTJin-hai Tang
Jin-hai Tang

22 November 2013 in Tumor Biology
Verified
Journal Article
Closed access
PDF file
WCWei-Xian Chen
Wei-Xian Chen
SZShanliang Zhong
Shanliang Zhong
MJMing-Hua Ji
Ming-Hua Ji
MPMeng Pan
Meng Pan
QHQing Hu
Qing Hu
JTJin-hai Tang
Jin-hai Tang